Robert Sahr is counsel in Choate’s IP and life sciences group. He develops strategies for life science companies to maximise exclusivity for medicines and diagnostics, in particular biologics. He concentrates his practice on building worldwide patent portfolios appropriately aligned with product life cycle. Having worked in research and discovery for a multinational pharmaceutical company, he knows the process, science, and business of bringing regulated products to market. Sahr received his JD from Indiana University School of Law, his PhD from Indiana University School of Medicine and his BA from the State University of New York at Albany.